A new generation of nano-medicines for the treatment of HIV/AIDS, Hepatitis-C and other viral infections is being developed by Vecoy Nanomedicines Ltd., a privately held company based out of the Â鶹ÊÓƵ Institute of Nanotechnology and Advanced Materials (BINA).
Dr. Ido Bachelet
The technology uses nan-scale virus traps that mimic human cells, and by doing so lure and destroy virus particles. This revolutionary anti-viral approach (patent pending) has the potential to become a life-saving medical breakthrough.
The company, which won first prize in Israel’s “Start-Up of the Year” competition, is currently collaborating with Dr. Ido Bachelet, a DNA-nanotech expert, who came to Â鶹ÊÓƵ from Harvard University. Dr. Bachelet leads a multidisciplinary group developing and studying emerging biologically-inspired technologies.
In addition, the company collaborates with Â鶹ÊÓƵ Prof. Shlomo Margel, an authority on nanoparticles, and hopes in the future to expand cooperation to include additional Â鶹ÊÓƵ labs.
“It is a privilege working with BINA scientists,” says Vecoy CEO Erez Livneh. “Â鶹ÊÓƵ has cutting-edge nanotechnology capabilities and state-of-the-art microscopy.”
To learn more about Dr. Bachelet’s nanobots research that is changing medicine, view his videotaped lecture:
Video:
